Robert R. Crichton

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease

Antonio Martín‐Bastida, Roberta J. Ward, Rexford D. Newbould et al. · Scientific Reports · 2017 · 355 citations · Full text

Metal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategies

Robert R. Crichton, David T. Dexter, Roberta J. Ward · Coordination Chemistry Reviews · 2007 · 250 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Molecular Neuroscience +8

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect

Johan R. Boelaert, J. Van Cutsem, M. de Locht et al. · Kidney International · 1994 · 167 citations · Full text

Hydroxypyridinone Chelators, Biochemistry, Medicine +6

Reductive mobilisation of ferritin iron

Felix Funk, Jean-Pierre Lenders, Robert R. Crichton et al. · European Journal of Biochemistry · 1985 · 167 citations · Full text

Iron storage in <i>Saccharomyces cerevisiae</i>

F. Raguzzi, Emmanuel Lesuisse, Robert R. Crichton · FEBS Letters · 1988 · 163 citations · Full text

Fungal Cell Biology, Iron Metabolism, Iron Storage +16